We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$602M
AUM Growth
+$46.8M
Cap. Flow
+$8.45M
Cap. Flow %
1.4%
Top 10 Hldgs %
66.65%
Holding
35
New
5
Increased
14
Reduced
12
Closed
3

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$29.2M
2
GILD icon
Gilead Sciences
GILD
+$13.3M
3
MRK icon
Merck
MRK
+$11.2M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.91M
5
PRGO icon
Perrigo
PRGO
+$4.75M

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$13.8M
2
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$12.3M
3
AGN
Allergan plc
AGN
+$10.8M
4
BSX icon
Boston Scientific
BSX
+$8.45M
5
LLY icon
Eli Lilly
LLY
+$5.82M

Sector Composition

Rank Sector Weight
1 Healthcare 98.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
1
Abbott
ABT
$175B
$64.9M 10.79%
1,064,562
-41,080
-4% -$2.49M
MRK icon
2
Merck
MRK
$315B
$55.5M 9.22%
957,694
+197,684
+26% +$11.2M
BAX icon
3
Baxter International
BAX
$11.7B
$53.2M 8.85%
721,058
+5,620
+0.8% +$396K
BMY icon
4
Bristol-Myers Squibb
BMY
$124B
$49.9M 8.3%
902,226
+540,220
+149% +$29.2M
BSX icon
5
Boston Scientific
BSX
$65.4B
$47.8M 7.94%
1,461,300
-280,080
-16% -$8.45M
SHPG
6
DELISTED
Shire pic
SHPG
$29M 4.82%
171,825
+6,850
+4% +$1.1M
AZN icon
7
AstraZeneca
AZN
$262B
$28.1M 4.67%
400,294
-2,724
-0.7% -$196K
RVTY icon
8
Revvity
RVTY
$12.3B
$26.6M 4.42%
362,956
-15,250
-4% -$1.14M
BIO icon
9
Bio-Rad Laboratories Class A
BIO
$8.15B
$24.9M 4.15%
86,449
-7,791
-8% -$2.15M
IART icon
10
Integra LifeSciences
IART
$1.5B
$21M 3.5%
326,659
-60,307
-16% -$3.73M
ELV icon
11
Elevance Health
ELV
$80.9B
$20.9M 3.48%
87,910
+2,000
+2% +$463K
GILD icon
12
Gilead Sciences
GILD
$167B
$20.7M 3.43%
291,600
+188,100
+182% +$13.3M
NUVA
13
DELISTED
NuVasive, Inc.
NUVA
$19.6M 3.26%
375,807
+3,810
+1% +$200K
LLY icon
14
Eli Lilly
LLY
$1.05T
$15.5M 2.58%
181,641
-70,873
-28% -$5.82M
PRGO icon
15
Perrigo
PRGO
$1.48B
$14.5M 2.42%
199,440
+61,600
+45% +$4.75M
IONS icon
16
Ionis Pharmaceuticals
IONS
$8.99B
$12.6M 2.1%
303,240
+29,740
+11% +$1.32M
UHS icon
17
Universal Health Services
UHS
$9.15B
$11M 1.83%
98,633
+11,660
+13% +$1.37M
LXRX icon
18
Lexicon Pharmaceuticals
LXRX
$1.06B
$10.4M 1.72%
862,602
+8,010
+0.9% +$81.9K
REGN icon
19
Regeneron Pharmaceuticals
REGN
$70.9B
$9.83M 1.63%
+28,500
New +$8.91M
LH icon
20
Labcorp
LH
$23.2B
$9.27M 1.54%
60,125
-38,117
-39% -$5.75M
IRWD icon
21
Ironwood Pharmaceuticals
IRWD
$635M
$8.1M 1.35%
506,077
-832,558
-62% -$12.3M
CLVS
22
DELISTED
Clovis Oncology, Inc.
CLVS
$7.91M 1.31%
173,892
+50,000
+40% +$2.43M
PTLA
23
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$7.58M 1.26%
200,800
+66,000
+49% +$2.52M
PDCO
24
DELISTED
Patterson Companies, Inc.
PDCO
$7.08M 1.18%
312,232
– –
CAH icon
25
Cardinal Health
CAH
$53.5B
$6.17M 1.02%
126,263
-100,000
-44% -$5.67M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2018 Portfolio in Review

As of Q2 2018, Sector Gamma AS held 35 positions worth $602M, up 8.4% from $555M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Sector Gamma AS's Q2 2018 filing shows 5 new, 14 increased, 12 reduced and 3 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 28,500 shares worth $9.83M. The largest sale was Tenet Healthcare, an estimated $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 99% a quarter earlier.

  • Sector Gamma AS's largest Q2 2018 buy was Regeneron Pharmaceuticals: 28,500 shares worth $9.83M.
  • Sector Gamma AS added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.2M increase.
  • Sector Gamma AS's biggest Q2 2018 reduction was Tenet Healthcare, cutting an estimated $13.8M.
  • Sector Gamma AS fully exited Allergan plc in Q2 2018, selling an estimated $10.8M.
  • Sector Gamma AS's ten largest holdings make up 67% of its $602M portfolio in Q2 2018.
  • Sector Gamma AS opened 5 new positions and closed 3 in Q2 2018.
  • Sector Gamma AS's portfolio value rose 8.4% quarter-over-quarter to $602M.

Based on Sector Gamma AS's 13F filing for Q2 2018, filed 2 Aug 2018.